Five Bipartisan Pharma Patent and Pricing Bills Shared in Senate

During the February 9, 2023 Executive Business Meeting, Senate Judiciary Committee reported Interagency Patent Coordination and Improvement Act of 2023, Prescription Pricing for the People Act of 2023, Preserve Access to Affordable Generics and Biosimilars Act, and more.

Related Keywords

United States , ,Trademark Office ,Human Services ,Senate Judiciary Committee ,Drug Administration ,Braun ,Business Meeting ,Patent Coordination ,Improvement Act ,People Act ,Affordable Generics ,Patients Act ,Interagency Patent Coordination ,Senators Durbin ,United States Patent ,Prescription Pricing ,Senators Grassley ,Federal Trade Commission ,Preserve Access ,Biosimilars Act ,Senators Klobuchar ,Stop Significant ,Time Wasting Abuse Limiting Legitimate Innovation ,New Generics ,Affordable Prescriptions ,Senators Cornyn ,Federal Trade Commission Act ,Federal Register Notice ,Legal ,Business ,Government ,Harmaceutical Patent Legislation ,Drug Pricing Legislation ,Ps 79 ,S 113 ,Bus 142 ,S 148 ,Ms 150 ,Senator Durbin ,Senator Tillis ,Senator Grassley ,Senator Coons ,